Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer)

Published:2022-01-25 Issue:3 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Falcon Silvia¹,Riva Luis²,Flores Christina³,Vera Delphis⁴,Pinto Joseph⁵,Gomez Henry⁶

Affiliation:

1. Department of Medical Oncology, Aliada, Lima 15036, Peru

2. Department of Medical Oncology, Clínica Internacional, Lima 15036, Peru

3. Faculty of Human Medicine, Universidad Peruana Cayetano Heredia, Lima 15102, Peru

4. Digital Business Transformation and Strategy, Laboratory Corporation of America Holdings (Labcorp), Burlington, NC 27251, USA

5. Center for Basic and Translational Research, Auna Ideas, Lima 15036, Peru

6. Department of Medical Oncology, Oncosalud‑AUNA, Lima 15036, Peru

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference32 articles.

1. Role of HER2 gene overexpression in breast carcinoma;Ménard;J Cell Physiol,2000

2. Breast cancer classification according to immunohistochemistry markers: Subtypes and association with clinicopathologic variables in a peruvian hospital database;Vallejos;Clin Breast Cancer,2010

3. Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients;Yábar;Mol Clin Oncol,2017

4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

5. Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: A systematic review and meta-analysis;Wu;Ther Clin Risk Manag,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3